OVER-THE-COUNTER (OTC) DRUGS
Regulatory Pathways
♦ Rx-to-OTC Switches
♦ OTC Monograph amendments
♦ Forced switch petitions
♦ Hatch-Waxman Exclusivity for OTC Switches
Labeling
♦ Reviews – format and substantive language requirements
♦ Acceptable/unacceptable claims
Promotion & Advertising
♦ FTC actions
♦ NAD proceedings
FDA Legal Services -- for the life of a Life Sciences company
Product/Issue Specific FDA Legal Services
|
Links to Our Other Services
Life Cycle FDA Legal Services
|
|
|
© 2012 Michael A. Swit. ALL RIGHTS RESERVED.
Questions?
Contact us @ 760-815-4762 or mswit@fdacounsel.com
|
|
|
 |
|
|
|
|
|
|
|